Skip to content
Medical InsightsKoreaMedical Insights Korea

Sexual Health

I tested positive for HPV. Does that mean my partner was unfaithful?

The test finds the virus. It does not date it, and it cannot say who it came from. That is not reassurance — it is the actual limit of what the result contains.

Answer

A positive HPV test says the virus is detectable now and says nothing about when it was acquired: HPV positivity fluctuates across a person's life, the virus can persist below the threshold at which tests detect it and be found again later, and what research calls clearance usually means only that viral DNA fell below the clinical detection level rather than that the infection ended — so a first positive result years into a relationship is entirely compatible with an infection acquired long before it, and the test cannot establish infidelity in either direction.

Key takeaways

  • HPV positivity fluctuates throughout life, and papillomaviruses can persist in a latent state after apparent disease clearance with sporadic recurrence.
  • In most studies the word clearance describes HPV DNA falling below the clinical detection level, which is why researchers in this field prefer the terms apparent clearance and subclinical persistence.
  • There is a lag phase between infection and any visible lesion, and its length depends on how much virus was transmitted, so the appearance of warts does not date the exposure either.
  • Among 44,065 Korean men tested for HPV between 2014 and 2022, 59.1 percent were positive and 49.3 percent of those carried more than one genotype.
  • A systematic review of eight longitudinal studies found consistent condom use offers relatively good but incomplete protection against HPV, since condoms do not cover all the skin involved in transmission.

This question is asked more often than it is answered, because the honest answer is uncomfortable for everyone involved and because the people usually asked — a clinic, a search result — have no incentive to sit with it. The test result does not contain the information the question is asking for.

What a positive result actually establishes

It establishes that HPV DNA is detectable in the sample taken, on the day it was taken. It does not establish when the virus arrived, and this is not a technicality about test accuracy. It follows from how the infection behaves.

A review of HPV latency and subclinical infection describes what cervical screening programmes made visible once DNA testing was introduced: many HPV-positive people are cytologically normal, and positivity fluctuates across a lifetime rather than following a single course from infection to resolution.

The practical consequence is stated in that paper directly: these concepts matter for managing patients whose HPV positivity appears some time after the onset of sexual activity. A first positive result in year eight of a relationship is one of the situations the biology predicts.

Warts do not date the exposure either

Between infection and a visible lesion there is a lag phase, and its length is not fixed. It depends on how much virus was transmitted, with multifocal infections progressing to visible disease faster than sparse ones.

So neither the test result nor the appearance of warts carries a date. Someone reasoning backwards from "this appeared last month, therefore it was acquired last month" is using an assumption the evidence does not support.

How common this is in Korea

59.1%

HPV positivity among 44,065 Korean men tested between 2014 and 2022, with 49.3 percent of positive men carrying more than one genotype

These were men who came for testing rather than a random sample, so the figure runs ahead of the general population. It still describes an infection so ordinary that treating a positive result as evidence about a relationship is reasoning from a common event to a specific explanation.

Korean national claims data points the same way from the treatment side: the number of men diagnosed with anogenital warts rose from 32,709 in 2007 to 114,734 in 2018, with the highest prevalence between ages 25 and 29.

Where condoms fit

A systematic review of eight longitudinal studies found that consistent condom use protects against HPV infection and supports regression of cervical lesions. Four of the eight reached statistical significance and the other four showed protection without reaching it.

The protection is real and partial. Condoms do not cover every area of skin involved in transmission, which is why consistent use lowers risk rather than removing it — and why a couple who used them is not thereby excluded from this situation.

What this does not say

  1. It does not say infidelity did not happen. The point is narrower and firmer: the test result is not evidence either way, and nothing in this article can tell anyone what happened in their relationship.
  2. It does not say recent transmission is unlikely. A new infection is one of several explanations consistent with a new positive result, and the evidence cannot rank them for an individual.
  3. Latency and subclinical persistence are established well enough to change how results are interpreted, but how often reactivation occurs, and in whom, is not settled.
  4. The 59.1 percent figure describes men who sought HPV testing, a group already more likely to be positive than the general population.
  5. The condom review covered cervical outcomes in women. It is evidence that condoms reduce transmission, not a measurement of protection in every situation.
  6. This is about what a test result means, not about screening decisions, treatment, or cancer risk, which are separate subjects.

The defensible summary is that a positive HPV test is a statement about the present and not about the past. It cannot date an infection, it cannot name a source, and a virus that persists below detection for years and reappears is ordinary rather than exceptional. Anyone using the result as evidence about a relationship is asking it a question it was never able to answer.

Sources

  1. Doorbar J

    The human Papillomavirus twilight zone - Latency, immune control and subclinical infection
  2. Jo SB, Ahn ST, Kim JW, Oh MM, Lee DS, Sohn YH, Moon DG

    Prevalence and genotype distribution of human papillomavirus among Korean males: Implications for vaccination strategies
  3. Lam JU, Rebolj M, Dugué PA, Bonde J, von Euler-Chelpin M, Lynge E

    Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies
  4. Chung H, Choi JB, Kim S, Lee SJ, Bae S

    Prevalence and economic burden of male anogenital wart in Korea: A population-based big data analysis from 2007 to 2018